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Abstract
Brain iron deposits (IDs) are indicative of microvessel dysfunction which may predispose to small vessel disease (SVD) brain
damage and worsen cognition later in life. Visible perivascular spaces in the centrum semiovale (CSO-PVS) are SVD features
linked with microvessel dysfunction. We examined possible associations of CSO-PVS volume and count with brain IDs and
cognitive abilities in 700 community-dwelling individuals from the Lothian Birth Cohort 1936 who underwent detailed cognitive
testing and multimodal brain MRI at mean age 72.7 years. Brain IDs were assessed automatically followed by manual editing.
PVS were automatically assessed in the centrum semiovale and deep corona radiata supraventricular. General factors of overall
cognitive function (g), processing speed (g-speed) and memory (g-memory) were used in the analyses. Median (IQR) volumes of
IDs and CSO-PVS expressed as a percentage of intracranial volume were 0.0021 (0.011) and 0.22 (0.13)% respectively. Median
count of CSO-PVS was 410 (IQR = 201). Total volumes of CSO-PVS and ID, adjusted for head size, were correlated (Spearman
ρ = 0.13, p < 0.001). CSO-PVS volume, despite being correlated with all three cognitive measures, was only associated with g-
memory (B = -114.5, SE = 48.35, p = 0.018) in general linear models, adjusting for age, sex, vascular risk factors, childhood
intelligence and white matter hyperintensity volume. The interaction of CSO-PVS count with diabetes (B = -0.0019, SE =
0.00093, p = 0.041) and volumewith age (B = 1.57, SE = 0.67, p = 0.019) were also associated with g-memory. Linear regression
models did not replicate these associations. Therefore, it does not seem that CSO-PVS burden is directly associated with general
cognitive ability in older age.
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Introduction
It is known that minerals accumulate in several brain regions
and cell types (Ward et al. 2014). Macro-aggregation of min-
erals with para−/ferromagnetic properties is distinguishable
on T2*-weighted gradient echo and susceptibility-weighted
(SWI) magnetic resonance imaging (MRI) (Valdes
Hernandez et al. 2012a). The mineral most commonly found
in these aggregates is iron. It mainly accumulates gradually
with age in areas associated with motor activity (Rouault
2013) (i.e. corpus striatus, substantia nigra and brainstem)
via dysfunctional brain regulatory mechanisms (McCarthy
and Kosman 2014), or as a residual from very small chronic
haemorrhages, namely microbleeds, in abnormal blood ves-
sels (i.e. capillaries) throughout the brain (Martinez-Ramirez
et al. 2014). The iron deposits (IDs) coming from these two
sources can aggregate with other minerals forming Bcalcified^
clusters (Ramonet et al. 2002; Valdes Hernandez et al. 2016;
Valdes Hernandez et al. 2014). Several MRI studies have re-
ported associations of these three forms of mineral accumula-
tions (Yates et al. 2014) with cognitive decline (Valdés
Hernández et al. 2015; Sullivan et al. 2009), neurodegenera-
tion (Graham et al. 2000; Thompson et al. 2001; Ke and Qian
2003), and perivascular spaces (PVS) in the white matter
(Charidimou et al. 2014).
As IDs reflect the presence of mineral deposition in the
perforating vessel walls, they likely indicate some degree of
microvessel dysfunction which may predispose to small ves-
sel disease (SVD) brain damage later in life. IDs have been
related to the drop in intelligence (IQ) between childhood and
old age: those having more IDs when older, having the worse
drop in IQ (Penke et al. 2012). Other indicators of low cogni-
tive performance in youth (e.g. years of education) have also
been associated with an increase in the risk of SVD imaging
markers in later life (Backhouse et al. 2017). Visible
perivascular spaces (PVS) are also a sign of microvessel dys-
function including increased blood brain barrier leakage
(Brown et al. 2018). They also play an essential role in main-
taining brain fluid balance and are thought to be part of the
pathogenic pathway to the development of SVD and its asso-
ciated brain damage. Moreover, serum markers of cerebral
amyloid angiopathy in individuals with abundant lobal
microbleeds have been associated with number of
microbleeds and burden of PVS specifically in the centrum
semiovale (CSO-PVS) (Charidimou et al. 2014; Ishikawa
et al. 2018), prompting researchers to suggest that prominent
CSO-PVS are a marker of amyloid deposition and hence re-
lated to microbleed formation (Ishikawa et al. 2018). The role
of PVS in cognition in the healthy elderly in relation to de-
clining cognition is, however, less clear. Some studies have
suggested that PVS in the basal ganglia (Passiak et al. 2019;
MacLullich et al. 2004) and hippocampus (Jimenez-Balado
et al. 2018) are associated with cognitive decline while two
meta-analyses (Hilal et al. 2018. Francis et al. 2019) have
found inconsistent results. The role of, specifically, CSO-
PVS in cognitive decline or impairment in adulthood has been
studied in the context of small vessel disease (Benjamin et al.
2018; Yao et al. 2014), stroke/transient ischaemic attack
(Hurford et al. 2014), hypertension (Uiterwijk et al. 2014),
and epidemiology (i.e. population from specific geographic
regions, e.g. Pomerania, Dijon, Hong Kong, Singapore)
(Hilal et al. 2018) with conflicting results. Given the societal
impact of dementia, the putative association between burden
of PVS in different brain regions and dementia and/or demen-
tia risk has been also explored (Francis et al. 2019; Debette
et al. 2019) with inconclusive results. To the best of our
knowledge the current literature lacks information of compu-
tational measures of CSO-PVS burden in community-
dwelling older individuals in relation to specific cognitive
domains. It is not known, therefore, whether CSO-PVS can
(or not) be considered a determinant of non-pathological cog-
nitive ageing.
Brain IDs and CSO-PVS have been separately associated
with the burden of white matter hyperintensities (WMH),
mainly thought to be of vascular origin, and whose progres-
sion has been linked to endothelial (Poggesi et al. 2015) and
blood-brain barrier permeability dysfunction (Wardlaw et al.
2013b), related to the formation of both iron deposits and PVS
burden (Valdes Hernandez et al. 2016). However, evidence of
association between increase number of PVS and WMH is
inconsistent and more data are needed (Francis et al. 2019).
Moreover, hypercholesterolaemia, hypertension, diabetes,
previous strokes and presence of cardiovascular disease have
been related previously to the presence of CSO-PVS
(Wardlaw et al. 2013a; Francis et al. 2019) and IDs (Valdes
Hernandez et al. 2015).
In a large narrow-age cohort of community-dwelling sep-
tuagenarian, we investigate whether volumes of PVS and IDs
are related to each other, and whether CSO-PVS volume and
count are associated with poorer cognition than that expected
for a given premorbid IQ. By seeking to answer these research
questions, we also explore the role of WMH and vascular risk
factors in CSO-PVS burden and how these in turnmight affect
cognition; seeking information that could explain the link be-
tween early life factors and greater SVD burden in later life.
We hypothesise that CSO-PVS and brain ID are associated
and that both, independently, have associations with cognitive
function in generally healthy older people. From this cohort,
previous research has reported independent associations be-
tween WMH, IDs and cognitive function (Valdes Hernandez
et al. 2013; Penke et al. 2012; Valdés Hernández et al. 2015),
and with other related factors (e.g. nutritional (Valdes-
Hernandez et al. 2014), or vascular risk (Aribisala et al.
2014a; Valdés Hernández et al. 2015)); the mediating role of
WMH on the associations between IDs and cognition (Valdes
Hernandez et al. 2016), and the association of PVS, WMH
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and markers of inflammation (Aribisala et al. 2014b) (http://
www.lothianbirthcohort.ed.ac.uk/).
Materials and methods
We analysed structural brainMRI and cognitive data from 701
community-dwelling individuals from the Lothian Birth
Cohort 1936 at mean age 72.7 years (SD 0.7, range 71.1 to
74.2), from whom written informed consent was obtained
under protocols approved by the Lothian (REC 07/MRE00/
58) and Scottish Multicentre (MREC/01/0/56) Research
Ethics Committees. From the MRI, brain IDs were assessed
automatically (Glatz et al. 2015) in a pipeline that clusters the
bimodal distribution of T1Wand T2*W intensities in the basal
ganglia and compares this distribution with that of normal
appearing tissue; an adaptive threshold is then applied to ob-
tain a robust estimate of the volume of T2*W hypointensities
that might correspond to brain IDs. WMH volume was
assessed semi-automatically (Hernandez et al. 2010) using a
multispectral colour-fusion segmentation scheme, and CSO-
PVS volume and count were obtained fully automatically
(Ballerini et al. 2018) after thresholding the output from a
multidimensional filter that enhances vessel-like structures
(Fig. 1). All MRI data, and the automatic and semi-
automatic methods used here are publicly available (see
Online Methods for details). The cognitive variables analysed
were general fluid intelligence (g), general information pro-
cessing speed (g-speed), and general memory (g-memory),
and intelligence (IQ) at age 11. They were generated using
principal component analysis from batteries of well-
validated cognitive tests (Penke et al. 2012). Age in days,
biological sex, and self-reported vascular risk factors (VRF)
(i.e. hypertension, hypercholesterolaemia, diabetes and histo-
ry of cardiovascular disease and stroke) were also used in the
analyses. We used MATLAB R2014a to perform linear re-
gression and general linear models (GLMs). Variables and
interaction terms for the GLMs were selected based on plau-
sibility from published analyses. All volumetric imaging mea-
surements used in these models were adjusted by head size.
For the linear regression models, a combined VRF variable
was obtained by summing all self-reported VRF by coding
present = 1, not present =0. GLM and regression models used
a sample size of 540, which is the number of individuals with
MRI datasets that provided accurate CSO-PVS measures (i.e.
volume and count). IBM SPSS Statistics (release 21.0.0.0,
2012) was used to calculate bootstrapped bivariate parametric
and non-parametric cross-correlations between the imaging
and cognitive variables, and generate the descriptive statistics
for all variables involved in the analyses. For the correla-
tions, cases were excluded pairwise from the 701 individ-
uals that comprised our initial sample, and the imaging
variables were also adjusted by head size. Parametric
correlations between raw ID volumes and cognition, raw
WMH and ID volumes, and raw WMH volumes and cog-
nition were not calculated as they have been reported
previously (Valdes Hernandez et al. 2015; Valdes
Hernandez et al. 2013). All results are given with a pre-
cision of two significant decimal places. Full details of the
sample, cognitive data used, MRI acquisition and process-
ing can be found in the Online Methods.
Results
Sample characteristics
The descriptive statistics of the imaging, self-reported
vascular risk factors and cognitive variables involved in
the analyses are given in Table 1. CSO-PVS were suc-
cessfully automatically assessed in 540 individuals, with
numbers of PVS ranging from 41 to 847, which represent
volumes from 0.24 ml to 8.28 ml (mean 3.29 ml, 0.22%
of the ICV). These correspond with neuroradiological rat-
ings in the Potter-Wardlaw scale (Potter et al. 2015) from
1 to 4 (median 2). IDs and WMH in this sample have been
characterised in detail previously (Valdes Hernandez et al.
2013; Valdes Hernandez et al. 2012b). Briefly, IDs were
assessed in 672/701 MRI datasets, who had the sequences
required for assessing mineral deposition. From these, IDs
were present in 490 participants. The median total volume of
IDs in the sample (i.e. n = 672) was 0.04 ml (0.003% of the
ICV), and the median load in those individuals who had them
was 0.10ml (0.007% of the ICV) (IQR 0.25ml), ranging from
0.0020 ml to 3.22 ml. The WMHmedian volume in this sam-
ple was 7.7 ml (0.53% of the ICV) (IQR = 13.33 ml) (Table 1).
Given the known association between biological sex and brain
ID burden (Valdes Hernandez et al. 2015) and reports that
considered sex differences, men may have greater PVS
volume than women, particularly in the white matter
(Ramirez et al. 2015); thus descriptive statistics are given
for each biological sex group. However, only the median
and distribution of PVS count significantly differed be-
tween men (median: 440, IQR: 229) and women (median:
375, IQR: 174) in this sample (p = 0.002 and p < 0.001
respectively). The number of men and women in the sam-
ple was balanced. The number of men with diabetes and
history of cardiovascular disease was approximately dou-
ble the number of women with these VRFs. This biolog-
ical sex difference was not observed for hypertension,
hypercholesterolaemia and previous strokes.
Bivariate relationships
The cross-correlation matrix showing the bootstrapped bivar-
iate associations among the cognitive ability measures and
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brain variables adjusted for head size is shown in Table 2. The
percentage of total ID volume in ICV was negatively correlat-
ed with general cognition (Spearman ρ = −0.090, p = 0.049).
CSO-PVS volume (also adjusted for head size) was negatively
correlated with general cognition (Spearman ρ = −0.095, p =
0.036), g-memory (Spearman ρ = −0.10, p = 0.029) and g-
speed (Spearman ρ = −0.11, p = 0.017). However, CSO-PVS
count was not related with the cognitive variables. The per-
centage of CSO-PVS volume in ICV and PVS count were
correlated with the other two imaging measurements adjusted
by head size: ID volumes (Spearman ρ = 0.13 and 0.14 p <
0.001) and WMH volume (Spearman ρ = 0.48 and 0.19 re-
spectively, p < 0.001) (Fig. 2, Table 2). The percentages of
WMH and ID volumes in ICV were not correlated.
General linear models and linear regression models
Association between CSO-PVS measures and total ID volume
GLM revealed that the percentage of CSO-PVS volume in
ICVwas not associated with the percentage of total ID volume
in ICV but with the load of WMH (B = 0.051 p < 0.01). The
same GLM, but using instead CSO-PVS count, yielded simi-
lar results with the association with WMH volume (B = 22.85
p < 0.01). However, in bothmodels, CSO-PVSmeasures were
associated with interaction factors between the percentage of
ID volume in ICV, various VRF, and the percentage of WMH
volume in ICV (Table 3). WMH were observed around CSO-
PVS in many cases (Fig. 2).
Fig. 1 Schematic representation of the automatic (light blue) and semi-
automatic (light yellow) image processing pipelines. Normal-appearing
white matter (WM) masks are obtained from combining T1- and T2-
weighted images (T1W and T2W respectively), whilst white matter
hyperintensity (WMH) masks are obtained from the FLAIR and T2*-
weighted colour combination. Brain iron deposits are obtained from
thresholding the outliers of the bimodal lower cluster of the T1- and
T2*-weighted images (T1Wand T2*Wrespectively). Perivascular spaces
(PVS) in the centrum semiovale (CSO) are obtained from thresholding
the T2W image after enhancing the tubular-like structures in the region of
interest
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Association between CSO-PVS measures and cognitive
indicators
As per GLMs, the percentage of CSO-PVS volume in ICVand
its interaction with age were associated with g-memory. The
interaction of CSO-PVS count with diabetes was also associ-
ated with g-memory (Table 3). For each cognitive measure as
an outcome variable, two linear regression models that used
the CSO-PVS volume adjusted by ICV as the dependent var-
iable, together with age, biological sex, percentage of WMH
volume in ICVand the combined VRF variable as covariates,
were used to re-evaluate the putative associations between
CSO-PVS volumes and cognitive indicators. One of these
models included age 11 IQ as covariate and the other did
not. Linear regression models could not confirm that the
CSO-PVS volume as percentage in ICV was associated with
any of the three cognitive measures analysed. From these
models, the percentage of WMH volume in ICV was the im-
aging parameter negatively associated with all cognitive var-
iables, with strength and significance levels similar to those
reported previously using structural equation models (Valdes
Hernandez et al. 2013). The same re-evaluation was done
using, instead, as independent variable, the number of CSO-
PVS counted yielding similar results.
Discussion
CSO-PVS volume, despite being correlated with the three
cognitive domains, was only weakly associated with g-
memory in this sample after accounting for age, biological
sex, white matter hyperintensity burden and VRFs in a model
that also considered the interactions of CSO-PVS burden with
age, cardiovascular risk factors and diabetes. From these
Table 1 Imaging volumetric
measures, vascular risk factors
and cognitive variables
considered in the analyses. Values
reported are mean (standard
deviation) unless indicated
otherwise
Parameter n Men (n = 373) Women (n = 328) Total (n = 701)
g factor 696 −0.020 (1.074) 0.054 (0.93) 0.014 (1.01)
g-speed 686 −0.047 (1.064) 0.058 (0.96) 0.0031 (1.02)
g-memory 681 −0.094 (1.073) 0.11 (0.95) 0.0025 (1.02)
Age 11 IQ 663 98.86 (16.52) 102.73 (13.73) 100.68 (15.39)
MMSE 700 28.56 (1.59) 28.98 (1.16) 28.76 (1.42)
Total ID vol (ml)† 672 0.046 (0.20) 0.036 (0.18) 0.040 (0.20)
CSO-PVS vol (ml) 540 3.41 (1.56) 3.14 (1.33) 3.29 (1.46)
WMH vol (ml)† 673 7.87 (13.22) 7.38 (13.83) 7.70 (13.33)
Hypertension (n(%)) 701 184 (26.25) 157 (22.35) 341 (48.6)
Diabetes (n(%)) 701 53 (7.56) 24 (3.44) 77 (11)
Hypercholesterolaemia (n(%)) 701 156 (22.25) 134 (19.25) 291 (41.5)
CVD (n(%)) 701 124 (17.69) 67 (9.51) 191 (27.2)
Stroke (n(%)) 700 69 (9.86) 55 (7.84) 124 (17.7)
Legend: n: valid sample size, WMH: white matter hyperintensities, ID: iron deposition, CSO-PVS: perivascular
spaces in the centrum semiovale and corona radiata supraventricular, CVD: history of cardiovascular disease, (†):
median (interquartile range) values as variables were not normally distributed
Table 2 Bivariate pairwise cross-correlations between the cognitive
and imaging variables evaluated. Spearman (ρ) values are given in the
triangle below the main diagonal and Pearson’s (r) values are given in the
upper triangle above the main diagonal. The significance level is indicat-
ed as follows: * p < 0.05, ** p < 0.001. All results are given with a
precision of two significant decimal places
g factor g-speed g-memory Age 11 IQ %Total ID vol.
in ICV (†)
%CSO-PVS
volume in ICV
CSO-PVS
count
%WMH vol.
in ICV (†)
g factor 1 0.76** 0.70** 0.60** −0.079 −0.11* −0.036 −0.18**
g-speed 0.74** 1 0.50** 0.42** −0.066 −0.12** −0.041 −0.20**
g-memory 0.68** 0.46** 1 0.55** −0.071 −0.11* −0.082 −0.14**
Age 11 IQ 0.56** 0.39** 0.54** 1 −0.0060 −0.057 −0.045 −0.048
%Total ID vol. in ICV (†) −0.090* −0.077 −0.087 −0.016 1 0.052 0.066 0.022
%CSO-PVS volume in ICV −0.095* −0.11* −0.10* −0.067 0.13** 1 0.82** 0.43**
CSO-PVS count −0.011 −0.033 −0.060 −0.033 0.14** 0.83** 1 0.088
%WMH volume in ICV (†) −0.18** −0.25** −0.14** −0.058 0.039 0.49** 0.19** 1
Legend: (†) Not normally distributed data
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models, the interaction of the number of CSO-PVS with dia-
betes and the volume of CSO-PVS with age were also asso-
ciated with g-memory. However, these associations could not
be reproduced on linear regression models, which did not
account for the interactions previously mentioned but evalu-
ated the possible influence of childhood intelligence. Thus, we
can conclude that in our cohort 1) the burden of CSO-PVS has
no direct association with general cognition at older age, and
2) the possible effect that the CSO-PVS burden could have in
general memory at older age could be moderated by the pres-
ence (or not) of diabetes and/or by age.
The first conclusion is in-line with those reported by other
studies that have explored the possibility of an association of
PVS burden with cognition in older people. A previous study
in a healthy ageing sample (100 men) reported a correlation of
PVS visual ratings in the basal ganglia and centrum semiovale
with specific cognitive tests: non-verbal reasoning and general
visuospatial ability (MacLullich et al. 2004). A population-
based study on 1778 non-demented participants from 65 to
80 years of age with a 4 year follow-up, concluded that base-
line PVS assessments were not associated with baseline cog-
nitive performance (Zhu et al. 2010). Although the same study
found that higher rating scores of PVS in the basal ganglia
were associated with cognitive decline after 4 years, this was
not the case for PVS scores in the white matter (i.e. CSO).
Studies have found associations between higher PVS scores in
the basal ganglia and poorer general cognition (Huijts et al.
2014; Hurford et al. 2014), but not between the latter and
either total or CSO PVS (i.e. visual scores, volumes or count)
(Benjamin et al. 2018; Molad et al. 2017). A meta-analysis of
the literature (Francis et al. 2019) only found one study
(Uiterwijk et al. 2014) that reported an association between
CSO-PVS and cognition, but with borderline significance.
Systematic literature reviews have not found enough evidence
to conclude on the possible association between CSO-PVS
and dementia or dementia risk (Francis et al. 2019; Debette
et al. 2019). Our results add to the hypotheses that basal gan-
glia and CSO might have different underlying small vessel
arteriopathies to which PVS are functionally linked (Hurford
et al. 2014). However, the variability in the associations re-
ported between PVS and cognition could be partly due to
studies having used PVS visual rating scores, and the relative-
ly lower sensitivity or perhaps higher heterogeneity of the
visual rating scales applied. Robust computational methods
to quantitatively assess PVS are emerging (Feldman et al.
2018; Dubost et al. 2019) in addition to the method applied
in this work (Ballerini et al. 2018). Cross-validation of their
results in different cohorts through a coordinated international
effort is now needed.
The second conclusion adds to the current knowledge on
the possible effects that the presence of CSO-PVS could have
on general memory in older age and opens an avenue of re-
search on mechanisms underlying the progression of CSO-
PVS. A large study of 1818 stroke- and dementia-free partic-
ipants, which assessed PVS specifically in the hippocampus, a
brain structure known to be associated with memory, failed to
find any association between the burden of PVS in this struc-
ture and baseline cognitive performance or incident dementia
in the 8-year follow-up (Yao et al. 2014). However, this study
did not assess PVS in the centrum semiovale and neither the
possible moderator role of diabetes, present only in 8% of the
sample. Moreover, it did not evaluate a general memory score,
but only visual memory. Risk factors for the presence of PVS
differ in various brain regions (Zhang et al. 2014). The burden
of WMH, known to have a strong negative association with
cognition, has been cited as the main risk factor for CSO-PVS
(Zhang et al. 2014). In our sample, the total volume of WMH
was the only covariate consistently associated with both CSO-
Fig. 2 3D representation of the distribution of total iron deposition, white
matter hyperintensity and centrum semiovale perivascular spaces
volumes adjusted by intracranial volume (ICV) in the sample (left) and
axial T2-weighted slice showing the perivascular spaces (red), white mat-
ter hyperintensities (green) and their overlap (yellow)
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Table 3 General linear models
Model no. Outcome Predictors (in addition to age and biological sex) Interaction terms
name name B SE p value name B SE p value
1 %CSO-PVS vol.
in ICV
% ID vol. in ICV 0.12 0.31 0.69 ID vol · WMH vol −0.39 0.15 0.011
% WMH vol. in ICV 0.051 0.0052 1.11e-20 ID vol · hypertension 1.083 0.36 0.0029
hypertension −0.0065 0.0092 0.48 ID vol · hypercholest. −0.59 0.32 0.065
diabetes 0.0061 0.013 0.64 ID vol · hist of CVD −0.88 0.37 0.019
Hypercholesterolaemia −0.0037 0.0094 0.70 ID vol · prev stroke 0.77 0.38 0.042
History of CVD 0.011 0.010 0.25
Previous stroke −0.017 0.012 0.15
2 CSO-PVS count % ID vol. in ICV 15.69 518.43 0.97 ID vol · WMH vol −371.46 256.13 0.15
% WMH vol. in ICV 22.85 8.61 0.0082 ID vol · hypertension 1709.10 600.60 0.0046
hypertension −20.085 15.33 0.19 ID vol · hypercholest. −1047.30 532.46 0.049
diabetes 28.23 21.77 0.19 ID vol · hist of CVD −1052.90 621.21 0.091
Hypercholesterolaemia 2.51 15.67 0.87 ID vol · prev stroke 1323.70 628.74 0.036
History of CVD 17.37 16.62 0.30
Previous stroke −39.77 19.93 0.046
3 g-factor % CSO-PVS vol. in ICV −83.65 45.22 0.065 CSO-PVS vol · age 1.15 0.62 0.065
% WMH vol. in ICV −0.15 0.052 0.0037 CSO-PVS vol · hist of CVD −0.32 0.98 0.74
hypertension −0.19 0.091 0.034 CSO-PVS vol · diabetes −1.33 1.37 0.33
diabetes 0.14 0.35 0.68
Hypercholesterolaemia −0.012 0.094 0.90
History of CVD 0.0043 0.24 0.98
Previous stroke −0.13 0.11 0.26
4 g-factor CSO-PVS count −0.044 0.029 0.13 CSO-PVS count · age 0.00061 0.00041 0.13
% WMH vol. in ICV −0.16 0.048 0.00086 CSO-PVS count · hist of CVD −0.00029 0.00065 0.66
hypertension −0.19 0.091 0.033 CSO-PVS count · diabetes −0.0012 0.00087 0.15
diabetes 0.39 0.41 0.35
Hypercholesterolaemia −0.020 0.094 0.83
History of CVD 0.063 0.30 0.83
Previous stroke −0.12 0.11 0.30
5 g-speed % CSO-PVS vol. in ICV −56.35 45.80 0.22 CSO-PVS vol · age 0.77 0.63 0.22
% WMH vol. in ICV −0.18 0.053 0.00087 CSO-PVS vol · hist of CVD −0.14 0.99 0.89
hypertension −0.13 0.092 0.14 CSO-PVS vol · diabetes −1.75 1.38 0.21
diabetes 0.15 0.35 0.66
Hypercholesterolaemia −0.11 0.095 0.25
History of CVD −0.019 0.25 0.94
Previous stroke −0.081 0.11 0.48
6 g-speed CSO-PVS count −0.037 0.030 0.22 CSO-PVS count · age 0.00051 0.00041 0.22
% WMH vol. in ICV −0.19 0.048 7.27e-05 CSO-PVS count · hist of CVD 0.00061 0.00066 0.36
hypertension −0.13 0.092 0.15 CSO-PVS count · diabetes −0.0014 0.00088 0.12
diabetes 0.34 0.42 0.42
Hypercholesterolaemia −0.10 0.095 0.29
History of CVD −0.31 0.30 0.31
Previous stroke −0.063 0.11 0.58
7 g-memory % CSO-PVS vol. in ICV −114.46 48.35 0.018 CSO-PVS vol · age 1.57 0.67 0.019
% WMH vol. in ICV −0.13 0.056 0.020 CSO-PVS vol · hist of CVD 0.15 1.045 0.88
hypertension 0.00035 0.097 0.99 CSO-PVS vol · diabetes −1.96 1.46 0.18
diabetes 0.16 0.37 0.67
Hypercholesterolaemia −0.064 0.10 0.52
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PVS and the three cognitive measures, an association that was
explored in detail previously (Valdes Hernandez et al. 2013),
and which has also been reported in patients with cerebral
small vessel disease (SVD) (Benjamin et al. 2018; Molad
et al. 2017). As well as increasing age, Type 2 diabetes is
known to be associated with higher WMH burden (Tamura
and Araki 2015). The inter-relations between WMH burden,
CSO-PVS volume and count, age, impaired glucose and insu-
lin transfer mechanisms and memory, although have been in-
dependently explored, warrant further research.
Our hypothesis that CSO-PVSwould be associatedwith ID
was partly prompted by studies that found associations be-
tween serum markers of cerebral amyloid angiopathy, number
of microbleeds and CSO-PVS burden (Charidimou et al.
2014; Ishikawa et al. 2018). A study on equal-sized samples
of Alzheimer’s disease (AD) patients and patients diagnosed
with vascular cognitive impairment reported CSO-PVS being
associated with AD and not with amyloid burden - a patho-
logical finding characteristic of AD - (Banerjee et al. 2017).
We obtained statistically significant non-parametric correla-
tions between CSO-PVS and total ID loads, but subsequent
evaluations showed no direct association between these imag-
ing markers. Interestingly, the number of CSO-PVS was as-
sociated with the interaction between ID volume adjusted by
head size and hypercholesterolaemia. In our cohort, IDs in the
corpus striatum, not brain microbleeds, determine the brain ID
burden (Valdes Hernandez et al. 2015), and they have been
found associated with hypercholesterolaemia (Valdes
Hernandez et al. 2015).
As the actual volume of iron accumulation in tissues cannot
be accurately determined using structural MRI techniques
(Valdés Hernández et al. 2015), our analyses are based on
volumetric measurements that, although accurate, reflect the
effect that iron particles in brain tissue have on the MR signal.
This is partly affected by the susceptibility of the metal/
metalloid particles influenced by their aggregation, proportion
and interaction with the underlying tissue among other factors
(Glatz et al. 2013) and merits more research. Due to the low
incidence of microbleeds in this cohort we did not analyse
them separately. Replication of our analyses on cohorts with
higher prevalence of this type of iron deposition is, therefore,
necessary. Another limitation is that it was possible to obtain
valid quantitative measures of CSO-PVS burden in only 77%
of the available datasets, mainly due to motion artefacts.
Although the fully automatic nature of these PVS measures
makes them robust against inter−/intra-observer variations,
the analyses were based on data from around 30% fewer in-
dividuals than the recruited sample. Also, given that we
analysed a year-of-birth cohort, we could not fully explore
the influence of age. However, the association between in-
creasing age and higher PVS burden in both: basal ganglia
and CSO, is well reported in the present literature (Francis
et al. 2019; Hilal et al. 2018; Debette et al. 2019).
However, despite these limitations, this paper adds to the
literature investigating the role that CSO-PVS play on cogni-
tion and their association with brain ID in a large cohort rep-
resentative of Bhealthy ageing^, the latter being explored here
for the first time. Amongst its strengths are the use of state-of-
the-art quantitative methods to assess CSO-PVS, IDs and
WMH volumes. Our study has both scientific and practical
values, adding information related to the putative mechanisms
underlying cognition, which could, in turn, help designing
interventions aimed at successful cognitive ageing. Our sam-
ple is representative of the ID distribution, CSO-PVS and
WMH load of community-dwelling septuagenarian
Caucasian individuals, being our study relevant for epidemi-
ological and ageing studies.
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